oceanrock
UK M&A Briefing
Oceanrock Consulting
UK M&A Intelligence: March 2026 | Mid-market resilience builds, exit pressure lingers, and aerospace IPOs test public appetite
264 deals tracked. Inflexion Private Equity and Houlihan Lokey Inc in the spotlight.
March saw 264 UK deals with £58.3bn in disclosed deal value, with mid-market activity remaining robust, driven by continued buy-and-build strategies across services and software. Selective biotech funding is emerging, while Doncasters’ IPO preparation provides a clearer signal on exit conditions than the predictable Technology and Business Services volume.
264UK Target Deals
£58.3bnDisclosed Value
57PE-Backed
Source: Mergermarket
Deal Activity by Sector · March 2026
Technology
60
Business Services
49
Financial Services
29
Industrials
21
Construction
14
Healthcare
13
Consumer
12
Leisure
9
+ 57 deals across other sectors · Source: Mergermarket
In the Spotlight
PE in the Spotlight
Inflexion Private Equity
Inflexion recently closed its latest European mid-market buyout fund at €4.5bn, significantly above its €3.75bn target. Fresh capital to deploy makes them a relevant conversation for mid-market business services or technology mandates in the £50m–£300m range.
Advisory in the Spotlight
Houlihan Lokey Inc
Houlihan Lokey advised on Maseco and Metric Search in March, and is also advising Healthxchange on a planned sale. The advisory pipeline across financial services and healthcare suggests Houlihan Lokey is active in sectors where regulatory complexity or specialist buyer universes create advisory value beyond simple auction mechanics.
Key Insights
01
Doncasters IPO test for aerospace exposure
Doncasters is preparing for a 2H26 IPO with expected 2026 EBITDA of $150m-$200m, having lined up Morgan Stanley, Jefferies, and Barclays. The test-the-waters process will show whether public market investors are willing to back aerospace metal products manufacturers at the valuations private equity achieved in 2021-2022, and the outcome will influence how other industrial sponsors think about exit routes for similar assets.
02
UK pensions reform is being cited as a structural tailwind for PE buyout flow
New UK pensions legislation is expected to expand the domestic PE buyout pool. If that capital materialises, it would increase competition for quality mid-market assets in the £50m-£250m range where boutique advisers currently have strong positioning.
03
The 2020/2021 PE vintage is attracting negative attention across Europe
CVC is attracting scrutiny over its 2021 private equity vintage despite record realisations. The observation suggests that even sponsors delivering distributions are facing questions about the valuation entry points and leverage levels used in 2021 buyouts, which may influence how LPs evaluate European mid-market fund commitments going forward.
Deal Highlights
Owen Mumford Ltd
Healthcare / MedTech
£150.0m
Medical device designer acquired by Embecta, a listed US diabetes injection specialist, in a clean strategic fit. Cross-border MedTech trade sale at this scale from a UK family-owned business is relatively uncommon and worth tracking as a comparable for similar mandates.
BVNK Holdings Ltd
Technology / FinTech
£1,350.4m
Coinbase reportedly won exclusivity in a bidding war that also involved Mastercard, valuing BVNK at around USD 2bn. A UK-headquartered crypto payments infrastructure business attracting that level of US strategic interest is a signal worth noting for any adviser with fintech exposure.
Immutrin Ltd
Healthcare / Biotech
£65.0m
Frazier Life Sciences led a syndicate into this UK biotech at £65m, representing meaningful institutional conviction in the underlying science. Frazier's involvement signals US life sciences capital is looking seriously at UK-based early clinical assets right now.
If you are running a mid-market process in Q2, this month’s data points to continued capital availability but more selective execution. Well-prepared assets in defensible sectors are clearing, while exit routes for larger or more cyclical assets remain dependent on timing and market windows.